Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential
Date: Nov-2019 | Id: MACRC-0112 | Geographical Scope: Global | Publisher: DPI Research
The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025. The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period: • Increased Disease Awareness • Approval/launches of the New Vaccines • Rising focus on immunization programs • Increasing government support for the vaccine development Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments. Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025. The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis and recent development. Other emerging players are making novel technology-based vaccines which are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases which are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens and recent development. Key Topics Covered in the Report: • The Market Size of the Global Human Vaccines Market • The Market Size of the Global Pediatric Vaccines Market • The Market Size of the Global Adult Vaccines Market • The Market Size of the 42 Leading Vaccines • The Market Size of the Pneumococcal Disease, Diphtheria, Tetanus and Pertussis (DTP), Influenza, Human Papilloma Virus (HPV), Meningococcal, Hepatitis, Measles, Mumps, and Rubella (MMR), Rotavirus, Varicella. • Thoroughly Evaluates Market Share of the Segments such as Disease Indications, End Users, Leading Vaccines, and Companies • Investigates the Key Growth Drivers and Restraints of the Global Human Vaccines Market • Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement • A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development • An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Platform Technology, and Recent Development Detailed Segmentation: Global Human Vaccines Market, By Disease Indication • Influenza • Meningococcal • Hepatitis • Rotavirus • Varicella • Pneumococcal Disease • Diphtheria, Tetanus and Pertussis (DTP) • Measles, Mumps, and Rubella (MMR) • Human Papilloma Virus (HPV) Global Human Vaccines Market, By End User • Pediatric Vaccines • Adult Vaccines Global Human Vaccines Market, By Leading Vaccines • Prevnar / Prevnar 13 • Gardasil / Gardasil 9 • Vaxigrip • Fluzone • Flublok • Varivax • Menactra • Proquad • Pneumovax 23 • Fluarix/FluLaval • Havrix/Twinrix/Engerix–B • Priorix, Priorix Tetra, Varilrix • M–M–R II • Adacel • Boostrix • Bexsero • Menveo • Cervarix • Trumenba • Shingrix • Pentacel, Pentaxim, Imovax, Hexaxim • Rotateq • Zostavax • Rotarix • Synflorix • Pediarix, Infanrix • Ticovac • Biken Ha • Tetrabik • Mearubik • Varicella (MTP) • Jebik V • Flumist/Fluenz • Bio Thrax • Dukoral • Ixiaro • In Live • HeaLive • BiLive • Anflu • EasySix • Imvamune Global Human Vaccines Market, By Key Players • Sanofi Pasteur • GlaxoSmithKline (GSK) • Merck • Pfizer • AstraZeneca • Mitsubishi Tanabe Pharma • Emergent Biosolutions • Astellas Pharma Inc. • Valneva • Seqirus • Bavarian Nordic • Sinovac • Panacea Biotec • Bharat Biotech • Serum Institute of India • Biological E. Limited Global Human Vaccines Market, By Emerging Players • Vaccitech • Janssen (Johnson & Johnson) • Novavax • VBI Vaccines • GeoVax • Moderna Inc • Biondvax • Integrated Biotherapeutics Inc • GeneOne Life Science • Profectus BioSciences • Pneumagen • Themis Bioscience • Xeme Biopharma Inc • Altimmune • Pfenex Inc • Northwest Biotherapeutics • OncBioMune Pharmaceuticals The Report Helps Answer the Following Questions: • What is the current size of the overall global human vaccines market? How much will this market be worth from 2019 to 2025? • What are the market shares of the leading segments of the global human vaccines market in 2018? • What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025? • What are the main drivers and restraints in the global human vaccines market? • What are the leading vaccines? What are their revenue potentials to 2025? • What are the major deals happenings in the global vaccines market? • Who are the leading companies and what are their activities, revenue, recent developments and prospects? • What are some of the most prominent human vaccines currently in development? What are their activities, platform technology and recent developments? • What are new diseases areas which the vaccines companies are exploring?
1. Executive Summary 2. Global Vaccines Market Size & Forecast (2015 – 2025) 3. Market Share Analysis of Global Vaccines Market (%) 3.1 Global Vaccines Market Share, By Disease 3.2 Global Vaccines Market Share, By End User 3.3 Global Vaccines Market Share, By Leading Vaccine 3.4 Global Vaccines Market Share, By Company 4. Global Vaccines Market – Key Market Dynamics 4.1 Key Market Drivers 4.2 Key Market Inhibitors 5. Global Vaccines Market, By Disease 5.1 Pneumococcal Disease 5.2 Diphtheria, Tetanus and Pertussis (DTP) 5.3 Influenza 5.4 Human Papilloma Virus (HPV) 5.5 Meningococcal 5.6 Hepatitis 5.7 Measles, Mumps, and Rubella (MMR) 5.8 Rotavirus 5.9 Varicella 5.10 Other Diseases 6. Global Vaccines Market, By End User 6.1 Pediatric Vaccines 6.2 Adult Vaccines 7. Global Vaccines Market, By Leading Vaccine 7.1 Prevnar / Prevnar 13 7.2 Gardasil / Gardasil 9 7.3 Vaxigrip 7.4 Fluzone 7.5 Flublok 7.6 Varivax 7.7 Menactra 7.8 Proquad 7.9 Pneumovax 23 7.10 Fluarix/FluLaval 7.11 Havrix/Twinrix/Engerix–B 7.12 Priorix, Priorix Tetra, Varilrix 7.13 M–M–R II 7.14 Adacel 7.15 Boostrix 7.16 Bexsero 7.17 Menveo 7.18 Cervarix 7.19 Trumenba 7.20 Shingrix 7.21 Pentacel, Pentaxim, Imovax, Hexaxim 7.22 Rotateq 7.23 Zostavax 7.24 Rotarix 7.25 Synflorix 7.26 Pediarix,Infanrix 7.27 Ticovac 7.28 Biken Ha 7.29 Tetrabik 7.30 Mearubik 7.31 Varicella (MTP) 7.32 Jebik V 7.33 Flumist/Fluenz 7.34 BioThrax 7.35 Dukoral 7.36 Ixiaro 7.37 InLive 7.38 HeaLive 7.39 BiLive 7.40 Anflu 7.41 EasySix 7.42 Imvamune 7.43 Other Vaccines 8. Major Deals and Agreement Happenings in the Global Vaccines Market 8.1 Merger & Acquisitions 8.2 Collaboration Deal 8.3 Licensing Agreement 8.4 Exclusive Agreement 8.5 Distribution Agreement 8.6 Partnerships 9. Key Players in the Global Vaccines Market 9.1 Sanofi Pasteur 9.1.1 Business Overview 9.1.2 Vaccines Portfolio 9.1.3 Vaccines Market Value Analysis & Forecast 9.1.4 Promising Vaccines in the Clinical Development 9.1.5 Recent Development 9.2 GlaxoSmithKline (GSK) 9.2.1 Business Overview 9.2.2 Vaccines Portfolio 9.2.3 Vaccines Market Value Analysis & Forecast 9.2.4 Promising Vaccines in the Clinical Development 9.2.5 Recent Development 9.3 Merck 9.3.1 Business Overview 9.3.2 Vaccines Portfolio 9.3.3 Vaccines Market Value Analysis & Forecast 9.3.4 Promising Vaccines in the Clinical Development 9.3.5 Recent Development 9.4 Pfizer 9.4.1 Business Overview 9.4.2 Vaccines Portfolio 9.4.3 Vaccines Market Value Analysis & Forecast 9.4.4 Promising Vaccines in the Clinical Development 9.4.5 Recent Development 9.5 AstraZeneca 9.5.1 Business Overview 9.5.2 Vaccines Portfolio 9.5.3 Vaccines Market Value Analysis & Forecast 9.5.4 Recent Development 9.6 Mitsubishi Tanabe Pharma 9.6.1 Business Overview 9.6.2 Vaccines Portfolio 9.6.3 Vaccine Market Value Analysis & Forecast 9.6.4 Promising Vaccines in the Clinical Development 9.6.5 Recent Development 9.7 Emergent BioSolutions 9.7.1 Business Overview 9.7.2 Vaccines Portfolio 9.7.3 Vaccine Market Value Analysis & Forecast 9.7.4 Promising Vaccines in the Clinical Development 9.7.5 Recent Development 9.8 Astlellas Pharma Inc 9.8.1 Business Overview 9.8.2 Vaccines Portfolio 9.8.3 Vaccines Market Value Analysis & Forecast 9.8.4 Recent Development 9.9 Valneva 9.9.1 Business Overview 9.9.2 Vaccines Portfolio 9.9.3 Vaccines Market Value Analysis & Forecast 9.9.4 Promising Vaccines in the Clinical Development 9.9.5 Recent Development 9.10 Seqirus 9.10.1 Business Overview 9.10.2 Vaccines Portfolio 9.10.3 Vaccine Market Value Analysis & Forecast 9.10.4 Promising Vaccines in the Clinical Development 9.10.5 Recent Development 9.11 Bavarian Nordic 9.11.1 Business Overview 9.11.2 Vaccines Portfolio 9.11.3 Vaccine Market Value Analysis & Forecast 9.11.4 Promising Vaccines in the Clinical Development 9.11.5 Recent Development 9.12 Sinovac 9.12.1 Business Overview 9.12.2 Vaccines Portfolio 9.12.3 Vaccine Market Value Analysis & Forecast 9.12.4 Promising Vaccines in the Clinical Development 9.12.5 Recent Development 9.13 Panacea Biotec 9.13.1 Business Overview 9.13.2 Vaccines Portfolio 9.13.3 Vaccine Market Value Analysis & Forecast 9.13.4 Promising Vaccines in the Clinical Development 9.13.5 Recent Development 9.14 Bharat Biotech 9.14.1 Business Overview 9.14.2 Vaccines Portfolio 9.14.3 Promising Vaccines in the Clinical Development 9.14.4 Recent Development 9.15 Serum Institute of India 9.15.1 Business Overview 9.15.2 Vaccines Portfolio 9.15.3 Promising Vaccines in Clinical Development 9.15.4 Recent Development 9.16 Biological E. Limited 9.16.1 Business Overview 9.16.2 Vaccines Portfolio 9.16.3 Promising Vaccines in Clinical Development 9.16.4 Recent Development 10. Emerging Players in the Global Vaccines Market 10.1 Vaccitech 10.1.1 Business Overview 10.1.2 Promising Vaccines in the Clinical Development 10.1.3 Recent Development 10.2 Janssen (Johnson& Johnson) 10.2.1 Business Overview 10.2.2 Promising Vaccines in the Clinical Development 10.2.3 Recent Development 10.3 Novavax 10.3.1 Business Overview 10.3.2 Promising Vaccines in the Clinical Development 10.3.3 Recent Development 10.4 VBI Vaccines 10.4.1 Business Overview 10.4.2 Promising Vaccines in the Clinical Development 10.4.3 Recent Development 10.5 GeoVax 10.5.1 Business Overview 10.5.2 Promising Vaccines in the Clinical Development 10.5.3 Recent Development 10.6 Moderna Inc 10.6.1 Business Overview 10.6.2 Promising Vaccines in the Clinical Development 10.6.3 Recent Development 10.7 Biondvax 10.7.1 Business Overview 10.7.2 Promising Vaccines in the Clinical Development 10.7.3 Recent Development 10.8 Integrated Biotherapeutics Inc 10.8.1 Business Overview 10.8.2 Promising Vaccines in the Clinical Development 10.8.3 Recent Development 10.9 GeneOne Life Science 10.9.1 Business Overview 10.9.2 Promising Vaccines in the Clinical Development 10.9.3 Recent Development 10.10 Profectus BioSciences 10.10.1 Business Overview 10.10.2 Promising Vaccines in the Clinical Development 10.10.3 Recent Development 10.11 Pneumagen 10.11.1 Business Overview 10.11.2 Promising Vaccines in the Clinical Development 10.11.3 Recent Development 10.12 Themis Bioscience 10.12.1 Business Overview 10.12.2 Promising Vaccines in the Clinical Development 10.12.3 Recent Development 10.13 Xeme Biopharma Inc 10.13.1 Business Overview 10.13.2 Promising Vaccines in the Clinical Development 10.13.3 Recent Development 10.14 Altimmune 10.14.1 Business Overview 10.14.2 Promising Vaccines in the Clinical Development 10.14.3 Recent Development 10.15 Pfenex Inc 10.15.1 Business Overview 10.15.2 Promising Vaccines in the Clinical Development 10.15.3 Recent Development 10.16 Northwest Biotherapeutics 10.16.1 Business Overview 10.16.2 Promising Vaccines in the Clinical Development 10.16.3 Recent Development 10.17 OncBioMune Pharmaceuticals 10.17.1 Business Overview 10.17.2 Promising Vaccines in the Clinical Development 10.17.3 Recent Development
Related reports
United States Influenza Vaccine Market
$1000-$1400
United States Blood Glucose Test Strips Market
$1290-$1990